Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Oct 12:13:1009038.
doi: 10.3389/fimmu.2022.1009038. eCollection 2022.

Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus

Andras Perl  1   2   3 , Nancy Agmon-Levin  4 , José C Crispín  5   6 , Trine N Jorgensen  7
Affiliations
Editorial

Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus

Andras Perl et al. Front Immunol. .
No abstract available

Keywords: biomarker; lupus (SLE); machine learning; multi-omics analyses; systems biology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic diagram of mTOR complexes 1 (mTORC1) and 2 (mTORC2) in SLE. Similar to rapamycin, fisetin inhibits both mTOR complexes (34), which may be involved in expanding Tregs (35) and thus improving depression and other organ involvement in SLE (10, 35).
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic New biomarkers for the diagnosis and treatment of systemic lupus erythematosus

References

    1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med (2011) 365:2110. doi: 10.1056/NEJMra1100359 - DOI - PubMed
    1. Trager J. And ward, m. m. 2001. mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol (2001) 13:345. doi: 10.1097/00002281-200109000-00002 - DOI - PubMed
    1. Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arth Rheumatol (2010) 39:257. doi: 10.1016/j.semarthrit.2008.10.007 - DOI - PMC - PubMed
    1. Francis L, Perl A. Pharmacotherapy of systemic lupus erythematosus. Expert Opin Pharmacother (2009) 10:1481. doi: 10.1517/14656560902971003 - DOI - PubMed
    1. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, et al. . Mortality in systemic lupus erythematosus. Arthritis Rheumatol (2006) 54:2550. doi: 10.1002/art.21955 - DOI - PubMed

Publication types